THIS IS HOW LUDICROUS THE WAR ON CHRONIC PAIN PATIENTS & THEIR DOCTORS REALLY IS!
THE POLITICIANS, POLICY MAKERS SHOULD BE EMBARRASSED AS HELL!
FACT:
-The overall mortality rate for prescription opioids is comparable to the fatality risk of one year of daily aspirin use! (From SAMHSA own 2017 estimates )
-In 2017, illegal heroin & Fentanyl accounted for more than three-fourths of all opioid overdose deaths.
The non-opioid antipsychotic drug Clozapine was found to have a sudden death rate of 0.71 percent for those treated with the drug in the sample …more dangerous than RX opioids!
Joshua T. Cohen and Peter J. Neumann, “What’s More Dangerous, Your Aspirin or Your Car? Thinking Rationally about Drug Risks (and Benefits),” Health Affairs 26, no. 3 (2007): 636-46. The authors find that daily aspirin use has a fatality risk of 10.4 per 100,000 person years, which translates to a 0.000104 fatality risk per year.
Our goal in this paper is to add to the policy debate about drug risks by comparing the mortality risks of common drugs with other risks people confront related to work, transportation, and recreation. Comparing risks in this way can provide a more intuitive sense of the magnitude of drug risks than stand-alone estimates can not.
To the Editor: Recently, we examined our current files to determine the incidence of narcotic addiction in 39,946 hospitalized medical patients' who were monitored consecutively.
Although there were 11,882 patients who received at least one narcotic preparation, there were only four cases of reasonably well documented addiction in patients who had a history of addiction. The addiction was considered major in only one instance. The drugs implicated were meperidine in two patients, Percodan in one, and hydromorphone in one.
"We conclude that despite widespread use of narcotic drugs in hospitals, the development of addiction is rare in medical patients with no history of addiction."
JANE PORTER & HERSHEL JICK, M.D. Boston Collaborative Drug Surveillance Program Boston University Medical Center
1986 paper on the "chronic use of opioid analgesics in non-malignant pain" by Dr. Russell Portenoy and Kathy Foley in Pain, the official journal of the American Pain Society.
"We conclude that opioid maintenance therapy can be a safe, salutary and more humane alternative to the options of surgery or no treatment in those patients with intractable non-malignant pain and no history of drug abuse," Portenoy and Foley wrote.
Long-Term Use and Addiction
The claim that long-term medical use generates addiction is the opposite of the consensus that began to emerge in the 1980s, which held that long-term medical use rarely generates addiction. Proponents of the standard explanation argue that, in coming to this more benign view of opioids, physicians and pharmaceutical companies relied excessively on a 1980 letter to the editor of The New England Journal of Medicine, which stated:
Although there were 11,882 patients who received at least one narcotic preparation, there were only four cases of reasonably well documented addiction in patients who had no history of addiction. . . . We conclude that despite widespread use of narcotic drugs in hospitals, the development of addiction is rare in medical patients with no history of addiction.
Advocates of the standard view argue that this letter provided insufficient grounds for the conclusion that long-term opioid use poses little risk of addiction, noting the letter’s brevity and limited peer review.
Studies since the 1980s, however, have consistently found only a modest risk of addiction or dependence from the medical use of opioids, in the range of 0 to 5 percent.
== A 2018 study of more than 568,000 patients receiving opioids between 2008 and 2016 found a “misuse” rate of 0.6 percent.
Reports of opioid abuse did not increase in the 1990s despite increased medical use. A substantial fraction of patients who exhibit addiction after medical use have a preexisting psychological disease or history of addiction According to the medical handbook Clinical Drug Data,
“addiction does not occur when these drugs are used for legitimate painful conditions.” ==
Part 1 of 2